Pregabalin Capsule 150 mg (Pregabalin)

Adult dose

This medication is administered orally divided into two doses per day regardless of food intake. 1. Neuropathic pain - Peripheral neuropathic pain: the initial dose of 150 mg per day can be administered, with possible titration to 300 mg per day within 3 to 7 days, and then to a maximum of 600 mg per day at 7-day intervals as necessary. - Central neuropathic pain: the initial dose of 150 mg per day can be administered, with titration to 300 mg per day after one week, up to the target daily dose of 600 mg after another week.

Child dose

There is insufficient safety and efficacy data for patients under the age of 12 and adolescents aged 12 to 17 years, so administration is not recommended.

This medication may increase the risk of suicidal thoughts or behaviors; it is important to immediately inform healthcare professionals of any mood changes or abnormal behavior during treatment. It should not be taken by individuals with hypersensitivity to this medication or specific genetic disorders such as lactase deficiency. Diabetes patients may experience changes in blood glucose control due to weight gain, necessitating adjustments to hypoglycemic medication. If symptoms of angioedema occur, the medication should be discontinued immediately, and caution is warranted in the elderly to prevent accidents due to dizziness or drowsiness. Changes in vision or visual disturbances may occur, so patients should consult healthcare professionals if any unusual symptoms arise. When taking this medication alone or in combination with other antiepileptic drugs, it should be done cautiously and under the direction of a healthcare professional; abrupt cessation may result in withdrawal symptoms. Due to the potential for drug abuse, patients with a history of mental disorders or drug abuse should exercise particular caution. Patients with impaired kidney function need dose adjustments, and those with heart conditions should consult healthcare providers before use. When taken with other medications that have central nervous system depressant effects, there is a risk of respiratory depression, so caution is necessary. Pregnant women should avoid use in early pregnancy due to the risk of fetal malformations, and women of childbearing potential should use effective contraception. Breastfeeding women should consider discontinuing breastfeeding or this medication due to the potential for transmission through breast milk. Dizziness or drowsiness may occur while taking this medication; therefore, it is safest to avoid driving or operating dangerous machinery. In cases of overdose, symptoms such as confusion, drowsiness, and depression may occur, and treatment such as hemodialysis may be necessary. Keep out of reach of children and avoid transferring to other containers.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, peeling skin, pain of oral/ocular mucosa, shortness of breath or breathing difficulties, asthma attacks, respiratory issues accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme drowsiness, sudden and severe headache, lightning-like headache, seizures, confusion of consciousness, visual disturbances, paralysis, urination

Mild side effects

• Dizziness
• drowsiness
• confusion
• disorientation
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a sealed container to prevent exposure to air or moisture, and it is recommended to keep it at a cool room temperature between 15 and 30 degrees Celsius.

Appearance

A hard capsule with a white upper part and a white lower part, containing white powder that is white or light yellow.

Package unit

30 capsules/bottle, 200 capsules/bottle